PHAT — Phathom Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $537.25m
- $600.63m
- $0.68m
Annual cashflow statement for Phathom Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -255 | -129 | -144 | -198 | -202 |
| Depreciation | |||||
| Non-Cash Items | 228 | 7.34 | 22.2 | 31.1 | 52.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.52 | 51.7 | -27.3 | 19.5 | 11.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -36.5 | -69.7 | -148 | -147 | -138 |
| Capital Expenditures | -0.132 | -1.04 | -0.328 | -1.04 | -1.63 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -25.1 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -25.3 | -1.04 | -0.328 | -1.04 | -1.63 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 305 | 114 | 44.7 | 120 | 368 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 243 | 43.7 | -104 | -27.5 | 228 |